Recycling Antibiotics into GUMBOS: A New Combination Strategy to Combat Multi-Drug-Resistant Bacteria
作者:Marsha Cole、Jeffery Hobden、Isiah Warner
DOI:10.3390/molecules20046466
日期:——
The emergence of multi-drug-resistant bacteria, coupled with the lack of new antibiotics in development, is fast evolving into a global crisis. New strategies utilizing existing antibacterial agents are urgently needed. We propose one such strategy in which four outmoded β-lactam antibiotics (ampicillin, carbenicillin, cephalothin and oxacillin) and a well-known antiseptic (chlorhexidine di-acetate) were fashioned into a group of uniform materials based on organic salts (GUMBOS) as an alternative to conventional combination drug dosing strategies. The antibacterial activity of precursor ions (e.g., chlorhexidine diacetate and β-lactam antibiotics), GUMBOS and their unreacted mixtures were studied with 25 clinical isolates with varying antibiotic resistance using a micro-broth dilution method. Acute cytotoxicity and therapeutic indices were determined using fibroblasts, endothelial and cervical cell lines. Intestinal permeability was predicted using a parallel artificial membrane permeability assay. GUMBOS formed from ineffective β-lactam antibiotics and cytotoxic chlorhexidine diacetate exhibited unique pharmacological properties and profound antibacterial activity at lower concentrations than the unreacted mixture of precursor ions at equivalent stoichiometry. Reduced cytotoxicity to invasive cell types commonly found in superficial and chronic wounds was also observed using GUMBOS. GUMBOS show promise as an alternative combination drug strategy for treating wound infections caused by drug-resistant bacteria.
多药耐药细菌的出现,加上新抗生素研发的缺乏,正迅速演变成一场全球危机。迫切需要利用现有抗菌剂的新策略。我们提出了一种策略,利用四种过时的β-内酰胺抗生素(阿莫西林、卡贝西林、头孢噻吩和克拉维酸)以及一种著名的防腐剂(双乙酰氯己定),将其制成基于有机盐的均匀材料组合(GUMBOS),以作为传统组合药物给药策略的替代方案。我们使用微量稀释法对25种具有不同抗生素耐药性的临床分离株,研究了前体离子(如双乙酰氯己定和β-内酰胺抗生素)、GUMBOS及其未反应混合物的抗菌活性。通过纤维芽细胞、内皮细胞和宫颈细胞系确定急性细胞毒性和治疗指数。肠道渗透性通过平行人工膜渗透性测定进行预测。由无效的β-内酰胺抗生素和具有细胞毒性的双乙酰氯己定形成的GUMBOS表现出独特的药理特性,并在比等当量前体离子未反应混合物更低的浓度下展现出显著的抗菌活性。使用GUMBOS时还观察到对常见于表浅和慢性创伤的侵袭性细胞类型的细胞毒性降低。GUMBOS在治疗由耐药细菌引起的创伤感染方面显示出作为替代组合药物策略的潜力。